Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

The 20 Most-Frequently Read Articles
Category: All

in J Clin Oncol during November 2014 -- updated monthly

Most-read rankings are recalculated at the beginning of the month and are based on abstract, full-text and pdf views.

1.  Edith A. Perez, Edward H. Romond, Vera J. Suman, Jong-Hyeon Jeong, George Sledge, Charles E. Geyer, Silvana Martino, Priya Rastogi, Julie Gralow, Sandra M. Swain, Eric P. Winer, Gerardo Colon-Otero, Nancy E. Davidson, Eleftherios Mamounas, Jo Anne Zujewski, Norman Wolmark
  Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831
  J. Clin. Oncol. Nov 20, 2014; 32: 3744-3752.
(In "Breast Cancer")   [Abstract]     [Full Text]     [PDF]
 
2.  Stephen J. Freedland, R. Bryan Rumble, Antonio Finelli, Ronald C. Chen, Susan Slovin, Mark N. Stein, David S. Mendelson, Colin Wackett, Howard M. Sandler
  Adjuvant and Salvage Radiotherapy After Prostatectomy: American Society of Clinical Oncology Clinical Practice Guideline Endorsement
  J. Clin. Oncol. Dec 01, 2014; 32: 3892-3898.
(In "ASCO SPECIAL ARTICLES")   [Abstract]     [Full Text]     [PDF]
 
3.  Douglas B. Johnson, Keith T. Flaherty, Jeffrey S. Weber, Jeffrey R. Infante, Kevin B. Kim, Richard F. Kefford, Omid Hamid, Lynn Schuchter, Jonathan Cebon, William H. Sharfman, Robert R. McWilliams, Mario Sznol, Donald P. Lawrence, Geoffrey T. Gibney, Howard A. Burris, Gerald S. Falchook, Alain Algazi, Karl Lewis, Georgina V. Long, Kiran Patel
  Combined BRAF (Dabrafenib) and MEK Inhibition (Trametinib) in Patients With <I>BRAF</I><SUP>V600</SUP>-Mutant Melanoma Experiencing Progression With Single-Agent BRAF Inhibitor
  J. Clin. Oncol. Nov 20, 2014; 32: 3697-3704.
(In "Rapid Communications")   [Abstract]     [Full Text]     [PDF]
 
4.  Natasha B. Leighl, Natasha Rekhtman, William A. Biermann, James Huang, Mari Mino-Kenudson, Suresh S. Ramalingam, Howard West, Sara Whitlock, Mark R. Somerfield
  Molecular Testing for Selection of Patients With Lung Cancer for Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Guideline
  J. Clin. Oncol. Nov 10, 2014; 32: 3673-3679.
(In "ASCO SPECIAL ARTICLES")   [Abstract]     [Full Text]     [PDF]
 
5.  Mariasanta Napolitano, Giorgia Saccullo, Alessandra Malato, Delia Sprini, Walter Ageno, Davide Imberti, Doris Mascheroni, Eugenio Bucherini, Pina Gallucci, Andrea D''Alessio, Tullia Prantera, Pietro Spadaro, Stefano Rotondo, Pierpaolo Di Micco, Vincenzo Oriana, Oreste Urbano, Francesco Recchia, Angelo Ghirarduzzi, Lucio Lo Coco, Salvatrice Mancuso
  Optimal Duration of Low Molecular Weight Heparin for the Treatment of Cancer-Related Deep Vein Thrombosis: The Cancer-DACUS Study
  J. Clin. Oncol. Nov 10, 2014; 32: 3607-3612.
(In "Cancer-Related Complications")   [Abstract]     [Full Text]     [PDF]
 
6.  Jennifer A. Ligibel, Catherine M. Alfano, Kerry S. Courneya, Wendy Demark-Wahnefried, Robert A. Burger, Rowan T. Chlebowski, Carol J. Fabian, Ayca Gucalp, Dawn L. Hershman, Melissa M. Hudson, Lee W. Jones, Madhuri Kakarala, Kirsten K. Ness, Janette K. Merrill, Dana S. Wollins, Clifford A. Hudis
  American Society of Clinical Oncology Position Statement on Obesity and Cancer
  J. Clin. Oncol. Nov 01, 2014; 32: 3568-3574.
(In "ASCO SPECIAL ARTICLES")   [Abstract]     [Full Text]     [PDF]
 
7.  Amye J. Tevaarwerk, Molin Wang, Fengmin Zhao, John H. Fetting, David Cella, Lynne I. Wagner, Silvana Martino, James N. Ingle, Joseph A. Sparano, Lawrence J. Solin, William C. Wood, Nicholas J. Robert
  Phase III Comparison of Tamoxifen Versus Tamoxifen Plus Ovarian Function Suppression in Premenopausal Women With Node-Negative, Hormone Receptor&#8211;Positive Breast Cancer (E-3193, INT-0142): A Trial of the Eastern Cooperative Oncology Group
  J. Clin. Oncol. Nov 17, 2014; doi: 10.1200/JCO.2014.55.6993.
(In "Breast Cancer")   [Abstract]     [PDF]
 
8.  Bella Kaufman, Ronnie Shapira-Frommer, Rita K. Schmutzler, M. William Audeh, Michael Friedlander, Judith Balma&ntilde;a, Gillian Mitchell, Georgeta Fried, Salomon M. Stemmer, Ayala Hubert, Ora Rosengarten, Mariana Steiner, Niklas Loman, Karin Bowen, Anitra Fielding, Susan M. Domchek
  Olaparib Monotherapy in Patients With Advanced Cancer and a Germline <I>BRCA1/2</I> Mutation
  J. Clin. Oncol. Nov 03, 2014; doi: 10.1200/JCO.2014.56.2728.
(In "Rapid Communications")   [Abstract]     [Full Text]     [PDF]
 
9.  Mary-Ellen Taplin, Bruce Montgomery, Christopher J. Logothetis, Glenn J. Bubley, Jerome P. Richie, Bruce L. Dalkin, Martin G. Sanda, John W. Davis, Massimo Loda, Lawrence D. True, Patricia Troncoso, Huihui Ye, Rosina T. Lis, Brett T. Marck, Alvin M. Matsumoto, Steven P. Balk, Elahe A. Mostaghel, Trevor M. Penning, Peter S. Nelson, Wanling Xie
  Intense Androgen-Deprivation Therapy With Abiraterone Acetate Plus Leuprolide Acetate in Patients With Localized High-Risk Prostate Cancer: Results of a Randomized Phase II Neoadjuvant Study
  J. Clin. Oncol. Nov 20, 2014; 32: 3705-3715.
(In "Urologic Oncology")   [Abstract]     [Full Text]     [PDF]
 
10.  Jos&eacute; Baselga, Javier Cort&eacute;s, Seock-Ah Im, Emma Clark, Graham Ross, Astrid Kiermaier, Sandra M. Swain
  Biomarker Analyses in CLEOPATRA: A Phase III, Placebo-Controlled Study of Pertuzumab in Human Epidermal Growth Factor Receptor 2&#8211;Positive, First-Line Metastatic Breast Cancer
  J. Clin. Oncol. Nov 20, 2014; 32: 3753-3761.
(In "Breast Cancer")   [Abstract]     [Full Text]     [PDF]
 
11.  Fredrik W&auml;rnberg, Hans Garmo, Stefan Emdin, Veronica Hedberg, Linda Adwall, Kerstin Sandelin, Anita Ringberg, Per Karlsson, Lars-Gunnar Arnesson, Harald Anderson, Karin Jirstr&ouml;m, Lars Holmberg
  Effect of Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma in Situ: 20 Years Follow-Up in the Randomized SweDCIS Trial
  J. Clin. Oncol. Nov 10, 2014; 32: 3613-3618.
(In "Breast Cancer")   [Abstract]     [Full Text]     [PDF]
 
12.  Wai-Kay Seto, Thomas S.Y. Chan, Yu-Yan Hwang, Danny Ka-Ho Wong, James Fung, Kevin Sze-Hang Liu, Harinder Gill, Yuk-Fai Lam, Albert K.W. Lie, Ching-Lung Lai, Yok-Lam Kwong, Man-Fung Yuen
  Hepatitis B Reactivation in Patients With Previous Hepatitis B Virus Exposure Undergoing Rituximab-Containing Chemotherapy for Lymphoma: A Prospective Study
  J. Clin. Oncol. Nov 20, 2014; 32: 3736-3743.
(In "Hematologic Malignancies")   [Abstract]     [Full Text]     [PDF]
 
13.  Bruce D. Cheson, Richard I. Fisher, Sally F. Barrington, Franco Cavalli, Lawrence H. Schwartz, Emanuele Zucca, T. Andrew Lister
  Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
  J. Clin. Oncol. Sep 20, 2014; 32: 3059-3067.
(In "SPECIAL ARTICLES")   [Abstract]     [Full Text]     [PDF]
 
14.  Reshma Jagsi, Manjeet Chadha, Janaki Moni, Karla Ballman, Fran Laurie, Thomas A. Buchholz, Armando Giuliano, Bruce G. Haffty
  Radiation Field Design in the ACOSOG Z0011 (Alliance) Trial
  J. Clin. Oncol. Nov 10, 2014; 32: 3600-3606.
(In "Rapid Communications")   [Abstract]     [Full Text]     [PDF]
 
15.  Eric J. Jacobs, Christina C. Newton, Victoria L. Stevens, Peter T. Campbell, Stephen J. Freedland, Susan M. Gapstur
  Daily Aspirin Use and Prostate Cancer&#8211;Specific Mortality in a Large Cohort of Men with Nonmetastatic Prostate Cancer
  J. Clin. Oncol. Nov 20, 2014; 32: 3716-3722.
(In "Urologic Oncology")   [Abstract]     [Full Text]     [PDF]
 
16.  Phuc Felix Nguyen-Tan, Qiang Zhang, K. Kian Ang, Randal S. Weber, David I. Rosenthal, Denis Soulieres, Harold Kim, Craig Silverman, Adam Raben, Thomas J. Galloway, Andr&eacute; Fortin, Elizabeth Gore, William H. Westra, Christine H. Chung, Richard C. Jordan, Maura L. Gillison, Marcie List, Quynh-Thu Le
  Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity
  J. Clin. Oncol. Dec 01, 2014; 32: 3858-3867.
(In "Head and Neck Cancer")   [Abstract]     [Full Text]     [PDF]
 
17.  Alan P. Venook, Josep Tabernero
  Progression-Free Survival: Helpful Biomarker or Clinically Meaningless End Point?
  J. Clin. Oncol. Nov 03, 2014; doi: 10.1200/JCO.2014.57.9557.
(In "EDITORIALS")   [Full Text]     [PDF]
 
18.  Richard Cedric Zellars
  New Information Prompts Old Question: Is Sentinel Lymph Node Sampling Equivalent to Axillary Lymph Node Dissection?
  J. Clin. Oncol. Nov 10, 2014; 32: 3583-3585.
(In "EDITORIALS")   [Full Text]     [PDF]
 
19.  Jeffrey B. Smerage, William E. Barlow, Gabriel N. Hortobagyi, Eric P. Winer, Brian Leyland-Jones, Gordan Srkalovic, Sheela Tejwani, Anne F. Schott, Mark A. O''Rourke, Danika L. Lew, Gerald V. Doyle, Julie R. Gralow, Robert B. Livingston, Daniel F. Hayes
  Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500
  J. Clin. Oncol. Nov 01, 2014; 32: 3483-3489.
(In "Rapid Communications")   [Abstract]     [Full Text]     [PDF]
 
20.  Claus R&ouml;del, Christian Weiss
  Organ-Sparing Multimodality Treatment for Muscle-Invasive Bladder Cancer: Can We Continue to Ignore the Evidence?
  J. Clin. Oncol. Dec 01, 2014; 32: 3787-3788.
(In "EDITORIALS")   [Full Text]     [PDF]
 
  
rss gif Subscribe to Most Read feed

Last Updated: 12/05/2014 19:39:04

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2014 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online